Spinal Accessory Nerve Injury Clinical Trial
Official title:
Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
NCT number | NCT03941327 |
Other study ID # | 2018-0212 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2019 |
Est. completion date | May 1, 2020 |
The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | May 1, 2020 |
Est. primary completion date | May 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: -Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the exclusion criteria. Exclusion Criteria: 1. History of modified radical neck dissection involving removal of spinal accessory nerve or sternocleidomastoid muscle 2. History of radical neck dissection 3. History of pre- existing disabling shoulder complaints 4. <18 years of age 5. Any individual unable to provide consent for his/her self. 6. Any individual with allergy, sensitivity, or aversion to porcine material. |
Country | Name | City | State |
---|---|---|---|
United States | University of Mississippi Medical Center | Jackson | Mississippi |
Lead Sponsor | Collaborator |
---|---|
University of Mississippi Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Shoulder function | Shoulder function will be assessed by Constant-Murley shoulder scale. The Constant-Murley shoulder scale is a validated subjective and objective survey of overall shoulder function. The scale ranges from 0 (no shoulder function) to 100 (perfect shoulder function). It consists of several questions about pain and disability as well as actual shoulder testing that will be performed by the consenting physician during the participant's clinic appointment. | The comparison of improvement or change in shoulder function over 6 months between the control and intervention groups will be the primary outcome measure. | |
Secondary | Postoperative pain following neck dissection: rate shoulder pain from 1-10 | The comparison of the improvement or change in pain scores over 6 months between the control group and intervention group will be assessed at each clinical visit over the course of 6 months. | Patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05399953 -
Investigation of Effects of Physiotherapy Interventions on Mechanical Properties of Muscle in Head and Neck Cancer
|
N/A |